Pharmacists have been on the frontlines of the COVID-19 pandemic for nine months and counting. Constant developments in Congress and federal agencies have implications for pharmacistsâ€™ practices. This presentation will review the "then and now" of governmental action in response to the COVID-19 pandemic and the impact of legislation and regulations on provider status efforts and pharmacistsâ€™ scope of practice.
Describe the governmental action (legislative and regulatory) to address COVID-19 and the impact on pharmacists’ practices.
List COVID-19 and non-COVID-19 examples of recent federal legislative activity that impact the practice of pharmacy.Â
Describe the latest COVID-19 and non-COVID-19 federal regulations related to the practice of pharmacy.Â